Follow the 테라젠이텍스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 테라젠이텍스 has logged 12 public disclosures. Market capitalisation: €78.9bn. The latest transaction was disclosed on 19 March 2026 (Purchase). Among the most active insiders: 테라젠이텍스. All data is openly available.
12
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 3,467 of 29,156 companies
72.2
score / 100
Value
87
Quality
58
FCF yld7.3%
Earn yld13%
EV/EBITDA4.6x
ROE·
Gross mgn52%
Net mgn3.9%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Teragen Etex is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions in the biotechnology field.